创新药板块年内大涨,似乎又打造了一个资本市场上中国崛起的故事。以港股市场为例,华泰柏瑞港股创新药ETF年内已经大涨57.87%,翻倍的个股更是屡见不鲜。“中国创新药企确实迎来了自己的‘Deepseek’时刻,而这一时刻的到来,是过去一二十年中国创新药企厚积薄发的结果。”国金证券研究所医药行业高级分析师赵海春对证券时报·券商中国记者表示。开源证券医药首席分析师余汝意则表示,国内创新药有望长期上行,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.